Zeria Pharmaceutical Co., Ltd. (TYO:4559)
2,145.00
+10.00 (0.47%)
May 8, 2026, 3:30 PM JST
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 92.41 billion as of May 8, 2026. Its market cap has decreased by -1.72% in one year.
Market Cap
92.41B
Enterprise Value
103.96B
Revenue
89.16B
Ranking
n/a
PE Ratio
11.18
Stock Price
2,145.00
Market Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 92.41B, an increase of 59.00%. That is a compound annual growth rate of 1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 92.41B | -0.13% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 246.56B |
| Towa Pharmaceutical | 192.48B |
| Kissei Pharmaceutical | 180.73B |
| Kaken Pharmaceutical | 153.37B |
| Mochida Pharmaceutical | 121.59B |
| KYORIN Pharmaceutical | 88.64B |
| ASKA Pharmaceutical Holdings | 83.29B |
| Fuji Pharma | 57.64B |